학술논문
Levonorgestrel 52 mg Intrauterine System Efficacy and Safety Through 8 Years of Use
Document Type
Academic Journal
Author
Source
Obstetrical & Gynecological Survey. Oct 01, 2022 77(10):592-593
Subject
Language
English
ISSN
0029-7828
Abstract
(Abstracted from Am J Obstet Gynecol 2022; doi: 10.1016/j.ajog.2022.05.022)Over the past several years, the longevity of use for long-acting reversible contraception (LARC) methods has increased. Increased duration of use is especially important for younger users desiring long-term birth prevention or spacing and for those who wish to postpone or avoid future childbearing.